John Lunger

Adaptimmune Therapeutics John Lunger

John Lunger is chief patient supply officer for Adaptimmune Therapeutics. 

More from John Lunger
Stock Shot
COVID-19 and the Impact on Supply Chains for Autologous Cell Therapies
The chain of custody for live cells is critical to ensuring the safe and timely treatment of patients.
May 20, 2020